Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Upstream Processing01:27

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypoperfusion in early-phase amyloid PET as a predictor of cognitive decline in Alzheimer's disease.

European journal of nuclear medicine and molecular imaging·2026
Same author

Montelukast as a novel therapeutic approach in metastatic uveal melanoma harboring a CYSLTR2 mutation: a translational case report.

ESMO open·2025
Same author

Treatment outcome of NSCLC patients with BRAF<sup>non-V600E</sup> mutations: a retrospective, multicentre analysis within the national Network Genomic Medicine (nNGM) Lung Cancer in Germany.

ESMO open·2025
Same author

Agreement between early-phase amyloid-PET and pulsed arterial spin labeling in a memory clinic cohort.

Journal of molecular medicine (Berlin, Germany)·2025
Same author

Resting-state functional connectivity abnormalities in subjective cognitive decline: A 7T MRI study.

Neurobiology of aging·2024
Same author

Reinventing ESMO after the COVID-19 pandemic: moving towards a sustainable academic society.

ESMO open·2024
Same journal

Automated colorimetric determination of recombinant fungal laccase activity in fermentation sarples using syringaldazine as chromogenic substrate.

The Journal of automatic chemistry·2008
Same journal

Diagnosis of infections in newborns using a new particle-mediated immunoassay for serum C-reactive protein.

The Journal of automatic chemistry·2008
Same journal

Automation photometer of Hitachi U-2000 spectrophotometer with RS-232C-based computer.

The Journal of automatic chemistry·2008
Same journal

An automated system for the measurement of hydrogen peroxide in industrial applications.

The Journal of automatic chemistry·2008
Same journal

Simultaneous spectrophotometric determination of manganese, zinc and cobalt by kernel partial least-squares method.

The Journal of automatic chemistry·2008
Same journal

The automatic methods group newsletter.

The Journal of automatic chemistry·2008
See all related articles

Related Experiment Video

Updated: Jun 28, 2026

Design and Implementation of a Bespoke Robotic Manipulator for Extra-corporeal Ultrasound
07:41

Design and Implementation of a Bespoke Robotic Manipulator for Extra-corporeal Ultrasound

Published on: January 7, 2019

Managing robotics in the generic pharmaceutical arena.

M Scheffler1

  • 1Danbury Pharmacal, Inc 12 Stoneleigh Avenue Carmel New York 10512 USA.

The Journal of Automatic Chemistry
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Danbury Pharmacal implemented robotics in 1987 to boost laboratory throughput. This case study examines key challenges including management acceptance, validation, and workflow optimization for new products.

More Related Videos

Simulation of a Scaled Assembly Process with Collaboration of a Robotic Arm and Monitoring through a Vision System for Quality Control
05:47

Simulation of a Scaled Assembly Process with Collaboration of a Robotic Arm and Monitoring through a Vision System for Quality Control

Published on: August 29, 2025

Robotic Sensing and Stimuli Provision for Guided Plant Growth
08:02

Robotic Sensing and Stimuli Provision for Guided Plant Growth

Published on: July 1, 2019

Related Experiment Videos

Last Updated: Jun 28, 2026

Design and Implementation of a Bespoke Robotic Manipulator for Extra-corporeal Ultrasound
07:41

Design and Implementation of a Bespoke Robotic Manipulator for Extra-corporeal Ultrasound

Published on: January 7, 2019

Simulation of a Scaled Assembly Process with Collaboration of a Robotic Arm and Monitoring through a Vision System for Quality Control
05:47

Simulation of a Scaled Assembly Process with Collaboration of a Robotic Arm and Monitoring through a Vision System for Quality Control

Published on: August 29, 2025

Robotic Sensing and Stimuli Provision for Guided Plant Growth
08:02

Robotic Sensing and Stimuli Provision for Guided Plant Growth

Published on: July 1, 2019

Area of Science:

  • Laboratory automation
  • Robotic systems in pharmaceutical manufacturing

Background:

  • Introduction of robotics by Danbury Pharmacal in 1987.
  • Objective to improve laboratory throughput for new products.

Purpose of the Study:

  • Overview of issues related to robotics implementation.
  • Analysis of challenges faced by Danbury Pharmacal.

Main Methods:

  • Case study analysis of Danbury Pharmacal's experience.
  • Qualitative review of implementation factors.

Main Results:

  • Identified critical success factors for robotics adoption.
  • Highlighted challenges in management and chemist acceptance.
  • Discussed political and validation hurdles.

Conclusions:

  • Robotics implementation requires strategic planning and stakeholder buy-in.
  • Successful integration depends on addressing technical and organizational challenges.
  • Automation can significantly enhance laboratory productivity and product throughput.